Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

NCT01298713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
mTor Protein

Interventions

DRUG: Tamoxifen
DRUG: Everolimus

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]